<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="viruses-12-00581-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">viruses-12-00581-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Antiviral activity of nylidrin and its analogues against influenza viruses, PR8, HK, and Lee.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Compound</th>
    <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">CC
     <sub>50</sub> (μM) 
     <sup>a</sup> to MDCK Cells
    </th>
    <th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">EC
     <sub>50</sub> (μM) 
     <sup>b</sup> against Influenza Viruses
     <break/>(S.I. 
     <sup>c</sup>)
    </th>
    <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Function</th>
   </tr>
   <tr>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A/ Puerto Rico/8/1934 (H1N1)</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A/Hong Kong/8/1968 (H3N2)</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B/Lee/40</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nylidrin</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">549.2 ± 0.5</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">7.2 ± 0.2</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">12.1 ± 1.6</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">β2-Adrenergic receptor agonist</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(76.3)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(45.4)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ifenprodil</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">488.2 ± 0.5</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">6.6 ± 0.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">16.9 ± 3.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">N-methyl-
     <sub>D</sub>-aspartate receptor 2B antagonist
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(74.0)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(29.0)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D. 
     <sup>d</sup>)
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Labetalol</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">498.1 ± 0.5</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">44.0 ± 9.7</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">α1- and β1/β2-Adrenergic receptor antagonist</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;11.3)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ritodrine</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">β2-Adrenergic receptor agonist</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Fenoterol</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">β2-Adrenergic receptor agonist</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Eliprodil</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">58.1 ± 6.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">N-methyl-
     <sub>D</sub>-aspartate antagonist
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;15.5)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Clenbuterol</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">9.4 ± 4.6</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">β2-Adrenergic receptor agonist</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;96.3)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Bambuterol</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">β2-Adrenergic receptor agonist</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AMT
     <sup>e</sup>
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.8 ± 0.1</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&gt;100.0</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">- 
     <sup>f</sup>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;1200)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(N.D.)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">RBV 
     <sup>g</sup>
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">18.4 ± 3.4</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">15.7 ± 2.7</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">13.8 ± 0.2</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">-</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;48.9)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;57.5)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;65.5)</td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">OSV-C 
     <sup>h</sup>
    </td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&gt;900.0</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.04 ± 0.01</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.005</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">0.8 ± 0.03</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">-</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;25,714)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;180,000)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(&gt;1125)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <sup>a</sup> 50% cytotoxic concentration (i.e., the concentration at which cell viability was reduced by 50%); 
    <sup>b</sup> 50% effective concentration [i.e., the concentration required to improve viability of influenza-infected Madin-Darby canine kidney (MDCK) cells by 50%]; 
    <sup>c</sup> Selectivity index (ratio of CC
    <sub>50</sub>/EC
    <sub>50</sub>); 
    <sup>d</sup> not determined; 
    <sup>e</sup> amantadine hydrochloride; 
    <sup>f</sup> control compound; 
    <sup>g</sup> ribavirin; 
    <sup>h</sup> oseltamivir carboxylate. 
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
